Metabolic Disorders Steering Committee

Myrlene Staten, M.D., National Institute of Diabetes and Digestive and Kidney Diseases, NIH (Co-Chair)
David Kelley, M.D., Merck & Co., Inc. (Co-Chair)
Patricia Andrade-Gordon, Ph.D., Johnson & Johnson Pharmaceutical Research & Development, LLC
Deborah Applebaum-Bowden, Ph.D., National Heart, Lung, and Blood Institute, NIH
John Backus, Ph.D., Ortho-Clinical Diagnostics
Karen Brown, Ph.D., DaiichiSankyo Pharma Development
Roberto A. Calle, M.D., Pfizer Global Research & Development
Paul M. Coates, M.D., Office of Dietary Supplements, NIH
Tamara Darsow, American Diabetes Association
Mark Deeg, M.D., Ph.D., Eli Lilly & Company
Deborah A. DeManno, Ph.D., Takeda Global R&D
Victor Dishy, M.D., Daiichi Sankyo Pharma Development
Joseph Frascella, National Institute on Drug Abuse, NIH
David Fryburg, M.D., ROI BioPharma Consulting
Judy Hannah, Ph.D., National Institute on Aging, NIH
William J. Heetderks, M.D., Ph.D., National Institute of Biomedical Imaging and BioEngineering, NIH
Claude Hughes, M.D., Ph.D., Quintiles, Inc.
Teresa L. Jones, M.D., National Institute of Diabetes & Digestive &Kidney Diseases, NIH
Young S. Kim, Ph.D., National Cancer Institute, NIH
Paul L. Kimmel, M.D., National Institute of Diabetes & Digestive &Kidney Diseases, NIH
David Maggs, M.D., Amylin
Rene Myers, Ph.D., BG-Medicine
John W. Newcomer, M.D., Washington University School of Medicine
Mary H. Parks, M.D., Center for Drug Evaluation and Research, FDA
David Recker, Takeda
James Revkin, M.D., Boehringer Ingelheim Pharma GmbH & Co.
Bruce S. Schneider, M.D., Center for Biologics Evaluation and Research, FDA
Robert Sherwin, M.D., Yale University
Pothur Srinivas, Ph.D., M.P.H., National Heart, Lung and Blood Institute, NIH
Elizabeth Stafford, Ph.D., Center for Devices and Radiological Health, FDA
David R. Vera, Ph.D., University of California, San Diego
Adrianne Wong,  Juvenile Diabetes Research Foundation International